Abstract
Purpose
To compare the clinical visual results and complications of laser-assisted subepithelial keratectomy (LASEK) and epipolis laser in situ keratomileusis (Epi-LASIK).
Methods
A retrospective analysis of a case series of eyes treated with LASEK or Epi-LASIK with a follow-up of six months was performed. Twenty-two eyes were treated with LASEK, and 20 eyes were treated using Epi-LASIK. The main outcome measures were uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), and manifest refraction at one week, one month, three months, and six months after refractive surgery, and the presence of any complications.
Results
There was no significant difference of UCVA and mean postoperative spherical equivalent (SE) between the eyes treated with LASEK or Epi-LASIK at one week, three months, and six months. However at one month there was significant difference of UCVA. Additionally, in a comparison between moderate and serve myopia, there was no significant difference of UCVA and mean postoperative spherical equivalent (SE) between groups treated with LASEK or Epi-LASIK at one week, one month, three months, and six months. Seven eyes treated with LASEK and two eyes treated with Epi-LASIK showed persistent epithelial erosion less than one week. Two eyes treated with LASEK exhibited newly-developed corneal opacity, which persisted-through the last visit.
References
1. Pallikaris IG, Papatzanak ME, Stathi EZ. Laser in situ keratomileusis. Laser Surg Med. 1990; 10:463–8.
2. Wilson SE. LASIK: management of common complications. Cornea. 1998; 17:459–67.
3. Wang Z, Chen J, Yang B. Posterior corneal surface topographic changes after laser insitu keratomileusis are related to residual corneal bed thickness. Ophthalmology. 1999; 106:406–9.
5. Seiler T, Quurke AW. Iatrogenic keratectasia after laser in situ keratomileusis. J Cataract Refract Surg. 1998; 24:1007–9.
6. Haw WW, Manche EE. Iatrogenic keratectasia after a deep primary keratotomy during laser in situ keratomileusis. Am J Ophthalmol. 2001; 132:920–1.
7. Lee JB, Choe CM, Kim HS, et al. Comparison of TGF-1 in tears following laser subepithelial cells: electron microscopic study. Cornea. 2002; 21:388–92.
8. Gabler B, Winkler MC, Deiss AK, et al. Vitality of epithelial cells after alcohol exposure during laser-assisted subepithelial keratectomy flap preparation. J Cataract Refract Surg. 2002; 28:1841–6.
9. Pallikaris JG, Naoumidi II, Kalyvianaki MI, et al. Epi-LASIK: Comparative histological evaluation of mechanical and alcohol-assisted epithelial separation. J Cataract Refract Surg. 2003; 29:1496–501.
10. Kornilovsky IM. Clinical results after subepithelial photorefractive keratectomy (LASEK). J Refract Surg. 2001; 17:S222–3.
11. Lee JB, Seong GJ, Lee JH, et al. Comparison of laser epithelial keratomileusis and photorefractive keratectomy for low to moderate myopia. J Cataract Refract Surg. 2001; 27:565–70.
12. Kamm O. The relation between structure and physiological action of the alcohols. J Am Pharm Assoc. 1921; 10:87–92.
13. Pallikaris IG, Katasanevaki VJ, Kalyvianaki MI. Advances in subepithelial excimer refractive surgery techniques : Epi-LASIK. Curr Opin Ophthalmol. 2003; 14:207–12.
14. Kwon HL, Kim KI, Koo BS, Park HR. Short term clinical results of laser epithelial keratomleusis and Epi-laser in situ keratomileusis for moderate and high myopia. J Korean Ophthalmol Soc. 2005; 46:1711–7.
15. Pallikaris IG, Kalyvianaki MI, Katasanevaki VJ, Ginis HS. Epi-LASIK : Preliminary clinical results of an alternative surface ablation procedure. J Cataract Refract Surg. 2005; 31:879–85.
16. Katsanevake VJ, Naoumidi II, Kalyvianaki MI, Pallikaris IG. Epi-LASIK : Histological findings of separated epithelial sheets 24 hours after treatment. J Refract Surg. 2006; 22:151–4.
17. Azar DT, Ang RT, Lee JB, et al. Laser subepithelial keratomileusis: electron microscopy and visual outcomes of flap photorefractive keratectomy. Curr Opin Ophthalmol. 2001; 12:323–8.
19. Pallikaris IG, Katasanevaki VJ, Kalyvianaki MI, Naoumidi II. Advances in subepithelial excimer refractive surgery techniques : Epi-LASIK. Curr Opin Ophthalmol. 2003; 4:207–12.
20. Anderson NJ, Beran RF, Schneider TL. Epi-LASIK for the correction of myopia and myopic astigmatism. J Cataract Refract Surg. 2002; 28:1343–7.
Table 1.
LASEK∗ | Epi-LASIK† | |
---|---|---|
Age (years) | 27.0±4.26 | 27.2±6.20 |
Sex | M:F=1:11 | M:F=1:10 |
Moderate myopia | 15 eyes | 15 eyes |
High myopia | 7 eyes | 5 eyes |
Total | 22 eyes | 20 eyes |
Manifest refractive error (SE‡) (D) | −5.48±1.18 | −4.96±1.17 |
Cycloplegic refractive error (SE) (D) | −5.02±1.18 | −4.70±1.16 |
Table 2.
Postoperative period |
||||||||
---|---|---|---|---|---|---|---|---|
1 week |
1 month |
3 months |
6 months |
|||||
LASEK | Epi-LASIK | LASEK | Epi-LASIK | LASEK | Epi-LASIK | LASEK | Epi-LASIK | |
Moderate myopia | 0.20±0.24 | 0.26±0.16 | 0.02±0.04 | 0.07±0.08 | 0.02±0.04 | 0.05±0.06 | 0.00±0.00 | 0.04±0.11 |
P‡ =0.285 | P=0.250 | P=0.202 | P=0.539 | |||||
High myopia | 0.31±0.16 | 0.52±0.18 | 0.17±0.17 | 0.42±0.71 | 0.06±0.09 | 0.10±0.07 | 0.08±0.14 | 0.02±0.05 |
P=0.05 | P=0.981 | P=0.343 | P=0.755 | |||||
Total | 0.23±0.22 | 0.33±0.20 | 0.06±0.11 | 0.15±0.37 | 0.02±0.06 | 0.06±0.07 | 0.02±0.08 | 0.03±0.10 |
P=0.125 | P=0.385 | P=0.057 | P=0.591 |
Table 3.
Postoperative period |
||||||||
---|---|---|---|---|---|---|---|---|
1 week |
1 month |
3 months |
6 months |
|||||
LASEK | Epi-LASIK | LASEK | Epi-LASIK | LASEK | Epi-LASIK | LASEK | Epi-LASIK | |
Moderate myopia | 0.38±1.23 | −0.3±0.67 | −0.73±0.17 | −0.12±0.68 | −1.00±1.13 | −0.34±0.48 | −0.57±0.51 | −0.470.40 |
P‡ =0.412 | P=0.267 | P=0.595 | P=0.567 | |||||
High myopia | −0.5±0.80 | −0.40±0.65 | −0.33±0.48 | −0.20±0.78 | −0.41±0.46 | −0.12±0.68 | −0.38±0.40 | −0.47±0.54 |
P=0.268 | P=0.755 | P=0.268 | P=0.876 | |||||
Total | −0.20±0.99 | −0.30±0.65 | −0.45±0.66 | −0.13±0.68 | −0.57±0.74 | −0.28±0.52 | −0.43±0.43 | −0.47±0.42 |
P=0.980 | P=0.235 | P=0.282 | P=0.611 |
Table 4.
Postoperative period |
||||||||
---|---|---|---|---|---|---|---|---|
1 week |
1 month |
3 months |
6 months |
|||||
visual acuity (logMAR‡) | SE† | visual acuity (logMAR) | SE | visual acuity (logMAR) | SE | visual acuity (logMAR) | SE | |
Moderate myopia | 0.20±0.20 | 0.38±1.23 | 0.02±0.04 | 0.73±0.17 | 0.02±0.04 | −1.00± 1.13 | 0.00±0.00 | −0.57±0.31 |
High myopia | 0.31±0.20 | 0.50±0.80 | 0.17±0.17 | 0.33±0.48 | 0.05±0.09 | −0.41±0.46 | 0.08±0.14 | −0.38±0.40 |
P§=0.142 | P=0.123 | P=0.026 | P=0.680 | P=0.630 | P=0.680 | P=0.298 | P=0.731 |
Table 5.
Postoperative period |
||||||||
---|---|---|---|---|---|---|---|---|
1 week |
1 month |
3 months |
6 months |
|||||
visual acuity (logMAR†) | SE‡ | visual acuity (logMAR) | SE | visual acuity (logMAR) | SE | visual acuity (logMAR) | SE | |
Moderate myopia | 0.26±0.20 | 0.30±0.67 | 0.07±0.08 | −0.12±0.68 | 0.05±0.06 | 0.34±0.48 | 0.04±0.11 | −0.47±0.40 |
High myopia | 0.52±0.20 | −0.40±0.65 | 0.42±0.71 | −0.20±0.78 | 0.10±0.07 | −0.12±0.68 | 0.02±0.05 | −0.47±0.54 |
P§=0.025 | P=0.800 | P=0.197 | P=0.672 | P=0.230 | P=0.395 | P=0.933 | P=0.933 |